Copeland, Robert A.
Accent Therapeutics,
United States
2025 Rank: 10250
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 165 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10250 | 11237 |
| Total Cites | 1035 | 1058 |
| H-index | 18 | 18 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 24 | 24 |
| Total Cites to Single Authored Papers | 159 | 162 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 276 | 280 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 415 | 420 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 798 | 814 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.30 |
| Self-Citation Percentage |
2.17%
|
|
Copeland, Robert A.
Accent Therapeutics,
United States
2024 Rank: 9159
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 165 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9159 | 8828 |
| Total Cites | 1142 | 1214 |
| H-index | 18 | 18 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 24 | 24 |
| Total Cites to Single Authored Papers | 156 | 167 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 280 | 299 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 417 | 451 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 855 | 876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.39 |
| Self-Citation Percentage |
5.93%
|
|
Copeland, Robert A.
Accent Therapeutics, Inc.,
United States
2023 Rank: 8752
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 181 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8752 | 10153 |
| Total Cites | 1260 | 1289 |
| H-index | 19 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 148 | 148 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 278 | 278 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 416 | 416 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 900 | 921 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.40 |
| Self-Citation Percentage |
2.25%
|
|
Copeland, Robert A.
Epizyme, Inc.,
United States
2022 Rank: 7010
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 165 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7010 | 7073 |
| Total Cites | 1370 | 1424 |
| H-index | 19 | 19 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 175 | 183 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 304 | 317 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 453 | 475 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 985 | 1000 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.42 |
| Self-Citation Percentage |
3.79%
|
|
Copeland, Robert A.
Inc,
United States
2021 Rank: 6614
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 149 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6614 | 7521 |
| Total Cites | 2086 | 2157 |
| H-index | 22 | 22 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 278 | 284 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 482 | 491 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 716 | 735 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1522 | 1551 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.39 |
| Self-Citation Percentage |
3.29%
|
|
Copeland, Robert A.
Accent Therapeutics, Inc,
United States
2020 Rank: 5932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 106 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5932 | 6882 |
| Total Cites | 1680 | 1728 |
| H-index | 19 | 19 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 20 | 20 |
| Total Cites to Single Authored Papers | 212 | 217 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 406 | 412 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 615 | 627 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1212 | 1233 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.40 |
| Self-Citation Percentage |
2.78%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.